Skip to main content
Equibles
BOLD logo

BOLD · Boundless Bio, Inc.

Track BOLD — free

Use BOLD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BOLD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.62 +0.03 (+1.16%) At close · Oct 2
Rebalance outlook locked
Market Cap
$58.23M
Shares
22.75M
Volume · Oct 2 156.53K Avg daily vol (3M) 185.45K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.62 Open$2.62 Day$2.55–2.70 52W close$1.05–3.00 Avg vol 30d126K Short int812K · 3.6% float · 12.2d Short vol56% DataMar 2024–Oct 2026 Filing10-Q · Aug 7

Up next

Latest filing: 10-Q
filed Aug 7, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$64.01M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-97.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$72.63M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.4%
Year over year · more shares
Price change (1Y)
+116.5%
Trailing year
Short interest
3.6%
Latest settlement · 12.2 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Bullish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +46%
above
Price vs 50-day avg −5%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 81%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −9%
trailing
6-month return +118%
trailing
YTD return +118%
this year
Relative strength +106%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $3 › 200d $2 — 50d above 200d
Institutional flow Accumulating
+11% holders QoQ · +13 funds added
Insider flow Accumulating
Net +$477.1K over 90 days · 50% sells
Short interest Falling
3.57% of float · ▼ -0.2% MoM · 12.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
40 holders — mid 2-yr range
Squeeze score 56
elevated · 0–100
Fundamentals
Fair
EPS growth +32%
Y/Y
Free cash flow $-47.2M
Quant / Vol
risk profile
Very High
Volatility 100%
annualized · 1-yr
Max drawdown −30%
past year
ATR 4.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+46% Bullish
Price vs 50-day avg
−5% Bearish
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
81% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $3 › 200d $2 — 50d above 200d
Institutional flow Accumulating
+11% holders QoQ · +13 funds added
Insider flow Accumulating
Net +$477.1K over 90 days · 50% sells
Short interest Falling
3.57% of float · ▼ -0.2% MoM · 12.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
40 holders — mid 2-yr range
Price context
position in its 52-week range
Range low $1 Now $3 · 81% Range high $3
vs 200-day avg +46% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BOLD
Boundless Bio, Inc.
this stock
$58.23M +118.3% — — 3.6%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $133.37B +11.3% +46.2% 30.7 1.9%
REGN
Regeneron Pharmaceuticals, Inc.
 $81.13B -4.8% +20.8% 19.5 2.5%
MRNA
Moderna, Inc.
 $79.40B +544.3% +4.3% — 8.2%
CSLLY
Csl Ltd
 $61.25B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
40
% held
67.3%
Net QoQ
+6.8M sh
Top holder
ARCH Venture Management,…
Held Float
View
Held by Funds
Fund positions
13
View
Short & Settlement
Short Interest Falling
Shares short
812.0K
Days to cover
12.2d
Change
-1.3K sh
View
Short Volume
Short vol %
56%
As of
Oct 2, 2026
Short Total
View
Fails to Deliver
FTD shares
1.3K
Value
$3.7K
As of
Aug 31, 2026
View
Off-Exchange
Off-exchange %
47.9%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$477.1K
Buyers / Sellers
1 / 1
Buyers Sellers
View
Financials
Financials
Net income (FY)
$-58.2M
EPS diluted
$-2.60
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 28, 2026
This year
11
View
Exempt Offerings
Offering
$100.0M
Filed
Aug 15, 2023
View
Earnings & Events
Webcasts
Last webcast
Jun 23, 2026
View
Investor Relations
Latest news
Boundless Bio and Serapha Bio Ann…
Published
Jun 23, 2026
View

Performance

5D 20D 120D MTD YTD
BOLD -1.5% -8.7% +118.3% +4.4% +118.3%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -1.3% -8.3% +106.2% +3.5% +105.5%
Key facts CIK 1782303 CUSIP 10170A100 13F (30d) 1 filings 1 filers Visit website Investor relations